United States Recombinant Human Endostatin Market Research Report Forecast 2017-2021

May 2017 | 124 pages | ID: U817955BE71EN
S&P Consulting

Abstracts

The United States Recombinant Human Endostatin Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the Recombinant Human Endostatin industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Recombinant Human Endostatin market study provides comprehensive data which enhances the understanding, scope and application of this report.

This report provides comprehensive analysis of

• Key market segments and sub-segments
• Evolving market trends and dynamics
• Changing supply and demand scenarios
• Quantifying market opportunities through market sizing and market forecasting
• Tracking current trends/opportunities/challenges
• Competitive insights
• Opportunity mapping in terms of technological breakthroughs

The Major players reported in the market include:

Pfizer
Biocon
Mabtech
Novartis
Fujifilm Kyowa Kirin Biologics
Enzon Pharmaceuticals
Genexine
Hetero Drugs
Onyx Pharmaceuticals

United States Recombinant Human Endostatin Market: Product Segment Analysis

• Type 1
• Type 2
• Type 3

United States Recombinant Human Endostatin Market: Application Segment Analysis

• Application 1
• Application 2
• Application 3

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

Contents

CHAPTER 1 RECOMBINANT HUMAN ENDOSTATIN MARKET OVERVIEW

1.1 Product Overview and Scope of Recombinant Human Endostatin
1.2 Recombinant Human Endostatin Market Segmentation by Type
  1.2.1 United States Production Market Share of Recombinant Human Endostatin by Type in 2015
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Recombinant Human Endostatin Market Segmentation by Application
  1.3.1 Recombinant Human Endostatin Consumption Market Share by Application in 2015
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Recombinant Human Endostatin (2011-2021)

CHAPTER 2 UNITED STATES ECONOMIC IMPACT ON RECOMBINANT HUMAN ENDOSTATIN INDUSTRY

2.1 United States Macroeconomic Analysis
2.2 United States Macroeconomic Environment Development Trend

CHAPTER 3 UNITED STATES RECOMBINANT HUMAN ENDOSTATIN MARKET COMPETITION BY MANUFACTURERS

3.1 United States Recombinant Human Endostatin Production and Share by Manufacturers (2015 and 2016)
3.2 United States Recombinant Human Endostatin Revenue and Share by Manufacturers (2015 and 2016)
3.3 United States Recombinant Human Endostatin Average Price by Manufacturers (2015 and 2016)
3.4 Manufacturers Recombinant Human Endostatin Manufacturing Base Distribution, Production Area and Product Type
3.5 Recombinant Human Endostatin Market Competitive Situation and Trends
  3.5.1 Recombinant Human Endostatin Market Concentration Rate
  3.5.2 Recombinant Human Endostatin Market Share of Top 3 and Top 5 Manufacturers
  3.5.3 Mergers & Acquisitions, Expansion

CHAPTER 4 UNITED STATES RECOMBINANT HUMAN ENDOSTATIN PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

4.1 United States Recombinant Human Endostatin Production and Market Share by Type (2012-2017)
4.2 United States Recombinant Human Endostatin Revenue and Market Share by Type (2012-2017)
4.3 United States Recombinant Human Endostatin Price by Type (2012-2017)
4.4 United States Recombinant Human Endostatin Production Growth by Type (2012-2017)

CHAPTER 5 UNITED STATES RECOMBINANT HUMAN ENDOSTATIN MARKET ANALYSIS BY APPLICATION

5.1 United States Recombinant Human Endostatin Consumption and Market Share by Application (2012-2017)
5.2 United States Recombinant Human Endostatin Consumption Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities
  5.3.1 Potential Applications
  5.3.2 Emerging Markets/Countries

CHAPTER 6 UNITED STATES RECOMBINANT HUMAN ENDOSTATIN MANUFACTURERS ANALYSIS

6.1 Pfizer
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Product Type, Application and Specification
  6.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Business Overview
6.2 Biocon
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Product Type, Application and Specification
  6.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Business Overview
6.3 Mabtech
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Product Type, Application and Specification
  6.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Business Overview
6.4 Novartis
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Product Type, Application and Specification
  6.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Business Overview
6.5 Fujifilm Kyowa Kirin Biologics
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Product Type, Application and Specification
  6.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Business Overview
6.6 Enzon Pharmaceuticals
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Product Type, Application and Specification
  6.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Business Overview
6.7 Genexine
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Product Type, Application and Specification
  6.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Business Overview
6.8 Hetero Drugs
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Product Type, Application and Specification
  6.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Business Overview
6.9 Onyx Pharmaceuticals
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Product Type, Application and Specification
  6.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Business Overview

CHAPTER 7 RECOMBINANT HUMAN ENDOSTATIN MANUFACTURING COST ANALYSIS

7.1 Recombinant Human Endostatin Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Recombinant Human Endostatin

CHAPTER 8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Recombinant Human Endostatin Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Recombinant Human Endostatin Major Manufacturers in 2015
8.4 Downstream Buyers

CHAPTER 9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

CHAPTER 10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

CHAPTER 11 UNITED STATES RECOMBINANT HUMAN ENDOSTATIN MARKET FORECAST (2017-2021)

11.1 United States Recombinant Human Endostatin Production, Revenue Forecast (2017-2021)
11.2 United States Recombinant Human Endostatin Production, Consumption Forecast by Regions (2017-2021)
11.3 United States Recombinant Human Endostatin Production Forecast by Type (2017-2021)
11.4 United States Recombinant Human Endostatin Consumption Forecast by Application (2017-2021)
11.5 Recombinant Human Endostatin Price Forecast (2017-2021)

CHAPTER 12 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Recombinant Human Endostatin
Table Classification of Recombinant Human Endostatin
Figure United States Sales Market Share of Recombinant Human Endostatin by Type in 2015
Table Application of Recombinant Human Endostatin
Figure United States Sales Market Share of Recombinant Human Endostatin by Application in 2015
Figure United States Recombinant Human Endostatin Sales and Growth Rate (2011-2021)
Figure United States Recombinant Human Endostatin Revenue and Growth Rate (2011-2021)
Table United States Recombinant Human Endostatin Sales of Key Manufacturers (2015 and 2016)
Table United States Recombinant Human Endostatin Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Recombinant Human Endostatin Sales Share by Manufacturers
Figure 2016 Recombinant Human Endostatin Sales Share by Manufacturers
Table United States Recombinant Human Endostatin Revenue by Manufacturers (2015 and 2016)
Table United States Recombinant Human Endostatin Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Recombinant Human Endostatin Revenue Share by Manufacturers
Table 2016 United States Recombinant Human Endostatin Revenue Share by Manufacturers
Table United States Market Recombinant Human Endostatin Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Recombinant Human Endostatin Average Price of Key Manufacturers in 2015
Figure Recombinant Human Endostatin Market Share of Top 3 Manufacturers
Figure Recombinant Human Endostatin Market Share of Top 5 Manufacturers
Table United States Recombinant Human Endostatin Sales by Type (2012-2017)
Table United States Recombinant Human Endostatin Sales Share by Type (2012-2017)
Figure United States Recombinant Human Endostatin Sales Market Share by Type in 2015
Table United States Recombinant Human Endostatin Revenue and Market Share by Type (2012-2017)
Table United States Recombinant Human Endostatin Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Recombinant Human Endostatin by Type (2012-2017)
Table United States Recombinant Human Endostatin Price by Type (2012-2017)
Figure United States Recombinant Human Endostatin Sales Growth Rate by Type (2012-2017)
Table United States Recombinant Human Endostatin Sales by Application (2012-2017)
Table United States Recombinant Human Endostatin Sales Market Share by Application (2012-2017)
Figure United States Recombinant Human Endostatin Sales Market Share by Application in 2015
Table United States Recombinant Human Endostatin Sales Growth Rate by Application (2012-2017)
Figure United States Recombinant Human Endostatin Sales Growth Rate by Application (2012-2017)
Table Pfizer Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Pfizer Recombinant Human Endostatin Production, Revenue, Price and Gross Margin (2012-2017)
Table Pfizer Recombinant Human Endostatin Market Share (2012-2017)
Table Biocon Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Biocon Recombinant Human Endostatin Production, Revenue, Price and Gross Margin (2012-2017)
Table Biocon Recombinant Human Endostatin Market Share (2012-2017)
Table Mabtech Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Mabtech Recombinant Human Endostatin Production, Revenue, Price and Gross Margin (2012-2017)
Table Mabtech Recombinant Human Endostatin Market Share (2012-2017)
Table Novartis Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Novartis Recombinant Human Endostatin Production, Revenue, Price and Gross Margin (2012-2017)
Table Novartis Recombinant Human Endostatin Market Share (2012-2017)
Table Fujifilm Kyowa Kirin Biologics Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Fujifilm Kyowa Kirin Biologics Recombinant Human Endostatin Production, Revenue, Price and Gross Margin (2012-2017)
Table Fujifilm Kyowa Kirin Biologics Recombinant Human Endostatin Market Share (2012-2017)
Table Enzon Pharmaceuticals Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Enzon Pharmaceuticals Recombinant Human Endostatin Production, Revenue, Price and Gross Margin (2012-2017)
Table Enzon Pharmaceuticals Recombinant Human Endostatin Market Share (2012-2017)
Table Genexine Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Genexine Recombinant Human Endostatin Production, Revenue, Price and Gross Margin (2012-2017)
Table Genexine Recombinant Human Endostatin Market Share (2012-2017)
Table Hetero Drugs Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Hetero Drugs Recombinant Human Endostatin Production, Revenue, Price and Gross Margin (2012-2017)
Table Hetero Drugs Recombinant Human Endostatin Market Share (2012-2017)
Table Onyx Pharmaceuticals Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Onyx Pharmaceuticals Recombinant Human Endostatin Production, Revenue, Price and Gross Margin (2012-2017)
Table Onyx Pharmaceuticals Recombinant Human Endostatin Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Recombinant Human Endostatin
Figure Manufacturing Process Analysis of Recombinant Human Endostatin
Figure Recombinant Human Endostatin Industrial Chain Analysis
Table Raw Materials Sources of Recombinant Human Endostatin Major Manufacturers in 2015
Table Major Buyers of Recombinant Human Endostatin
Table Distributors/Traders List
Figure United States Recombinant Human Endostatin Production and Growth Rate Forecast (2017-2021)
Figure United States Recombinant Human Endostatin Revenue and Growth Rate Forecast (2017-2021)
Table United States Recombinant Human Endostatin Production Forecast by Type (2017-2021)
Table United States Recombinant Human Endostatin Consumption Forecast by Application (2017-2021)